Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Xiaocong Zuo"'
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundOverweight and obesity are well-known risk factors for developing type 2 diabetes (T2DM). However, details on the evolution of the T2DM burden attributed to China’s high body mass index (BMI) in China have not been thoroughly studied. Thi
Externí odkaz:
https://doaj.org/article/a01cb84ad7ec4fb28812c2fa65a28df5
Autor:
Jianglin Wang, Xin Hu, Wei Jiang, Wenjie Zhou, Mengjie Tang, Cuifang Wu, Wei Liu, Xiaocong Zuo
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundPembrolizumab, a programmed cell death protein 1 checkpoint inhibitor, is a novel drug used to treat a variety of advanced malignancies. However, it can also result in many immune-related adverse events, with cutaneous toxicities being the
Externí odkaz:
https://doaj.org/article/88b3556f681f48cfa4dbf75bab4c1a55
Publikováno v:
Frontiers in Nutrition, Vol 10 (2023)
BackgroundHigh sodium intake is a crucial risk factor for the development and progression of chronic kidney disease (CKD). However, the latest global spatiotemporal patterns of CKD burden attributable to high sodium intake still remain unclear. We ai
Externí odkaz:
https://doaj.org/article/f6d96741c09146f5b8af084187654e3e
Autor:
Chen Shi, Zhaoming Ye, Zengwu Shao, Bifa Fan, Cibo Huang, Yuan Zhang, Xinying Kuang, Liyan Miao, Xin’an Wu, Rongsheng Zhao, Xiao Chen, Bikui Zhang, Rongsheng Tong, Xin Hu, Zhijian Fu, Jianhao Lin, Xiaomei Li, Tiezheng Sun, Guoqiang Liu, Haibin Dai, Cheng Guo, Bo Zhang, Ting Xu, Aidong Wen, Xiaocong Zuo, Jinmei Liu, Xu Chen, Huibo Li, Jing Wang, Min Luo, Tingting Fan, Yulan Qian, Xiu’mao Li, Wenjie Qiu, Xiaowen Lin, Yingchang Pang, Yunfei Hou, Difei Yao, Wen Kou, Bao Sun, Can Hu, Yanzhe Xia, Ming Zhao, Changyu Zhu, Qian Li, Yu Zhang
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 4, p 1544 (2023)
(1) Background: Topical non-steroidal anti-inflammatory drugs (NSAIDs) are one of the primary drugs for treating musculoskeletal pain. However, there are currently no evidence-based recommendations about drug selection, drug administration, drug inte
Externí odkaz:
https://doaj.org/article/4e08f7f349cb43b8a20d5d627cd39cb7
Autor:
Wenjun Yin, Ge Zhou, Lingyun Zhou, Mancang Liu, Yueliang Xie, Jianglin Wang, Shanru Zuo, Kun Liu, Can Hu, Linhua Chen, Huiqin Yang, Xiaocong Zuo
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background Pre-operative risk scores are more valuable than post-procedure risk scores because of lacking effective treatment for contrast-induced acute kidney injury (CI-AKI). A number of pre-operative risk scores have been developed, but d
Externí odkaz:
https://doaj.org/article/26a7e344b25b4fe5b2db2825aeb34832
Autor:
Chan Zou, Xiaocong Zuo, Jie Huang, Ye Hua, Shuang Yang, Xiaoyan Yang, Can Guo, Hongyi Tan, Jun Chen, Zhaoxing Chu, Qi Pei, Guoping Yang
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Background and Objective: Inhibition of thrombosis and platelet aggregation through a thromboxane synthetase inhibitor proved to be an effective and promising treatment for cardiovascular and/or cerebrovascular disease (CCVD) patients. This phase I s
Externí odkaz:
https://doaj.org/article/795b98ae637f49b6854ba151d202f3c1
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 6, Iss 3, Pp 183-188 (2016)
High mobility group box 1 (HMGB1) is a nuclear protein that can bind to DNA and act as a co-factor for gene transcription. When released into extracellular fluid, it plays a proinflammatory role by acting as a damage-associated molecular pattern mole
Externí odkaz:
https://doaj.org/article/c9e199f59cc94ea79d4e1febe3e2cd5c
Autor:
Xiaofen Liu, Chenrong Huang, Phillip J. Bergen, Jian Li, Jingjing Zhang, Yijian Chen, Yongchuan Chen, Beining Guo, Fupin Hu, Jinfang Hu, Linlin Hu, Xin Li, Hongqiang Qiu, Hua Shao, Tongwen Sun, Yu Wang, Ping Xu, Jing Yang, Yong Yang, Zhenwei Yu, Bikui Zhang, Huaijun Zhu, Xiaocong Zuo, Yi Zhang, Liyan Miao, Jing Zhang
Publikováno v:
J Zhejiang Univ Sci B
Polymyxin B, which is a last-line antibiotic for extensively drug-resistant Gram-negative bacterial infections, became available in China in Dec. 2017. As dose adjustments are based solely on clinical experience of risk toxicity, treatment failure, a
Publikováno v:
Journal of Biochemical and Molecular Toxicology. 37
Contrast-induced nephropathy (CIN) is an acute kidney injury (AKI) observed after the administration of contrast media. Calcium channel blockers (CCBs) have been reported to exert a renal protective effect. This study aims to investigate the role of
Publikováno v:
Gynecologic oncology. 168
The GOG 281/LOGS trial found that trametinib prolonged progression-free survival (PFS) in patients with recurrent low-grade serous ovarian cancer (LGSOC), compared with standard of care (SOC). The current study aimed to evaluate the cost-effectivenes